Ann: $2.0M extension to milestone deal with South Tees NHS Trust, page-8

Don't get me wrong - it's great news and shows that they're very happy working with Alcidion. However $2m over 5 yrs isn't a company maker.
Certainly each of these announcements and improvements in revenue is a positive and heightens my perception of ALC. However I don't think it's cheap at these levels.

A 3rd and/or 4th NHS contract is likely to be a tipping point for the share price.
That really would set up the revenue for the coming years and impress the market (and conservative investors like me) that ALC can continue to deliver in the years ahead.